• On June 15, 2026, Ventas, Inc. disclosed that Executive Vice President and General Counsel Carey S. Roberts resigned, effective June 26, 2026, with long-time deputy Kevin M. Bohl assuming her responsibilities on an interim basis.
• Roberts’ move to Blackstone’s real estate arm highlights the appeal of healthcare-related property expertise across large investment platforms and may refocus attention on Ventas’s governance bench strength.
• Against this backdrop, we’ll explore how Ventas’s robust senior housing performance and recent leadership transition could influence its existing investment narrative.

Find 45 companies with promising cash flow potential yet trading below their fair value.

Ventas Investment Narrative Recap

To own Ventas, you need to believe in the long-term demand for senior housing and healthcare real estate, supported by improving portfolio performance and disciplined capital allocation. The resignation of General Counsel Carey Roberts, with long-tenured deputy Kevin Bohl stepping in on an interim basis, does not appear to alter near term operating catalysts, but it does put a spotlight on legal, compliance and governance continuity as the company pursues its external growth agenda.

The most relevant recent update here is Ventas’ raised 2026 net income guidance, which management tied to stronger senior housing property performance and accretion from investment activity, partly offset by higher interest expectations. That outlook reinforces why execution on acquisitions and integrations remains central to the story, even as the legal leadership transition reminds investors that governance and risk management need to keep pace with a busier transaction pipeline.

Yet investors should be aware that as the Senior Housing Operating Portfolio grows, exposure to operator execution and occupancy risk could...

Ventas' narrative projects $8.5 billion revenue and $727.1 million earnings by 2029.

Uncover how Ventas' forecasts yield a $96.80 fair value, a 19% upside to its current price.

Exploring Other Perspectives

Three fair value estimates from the Simply Wall St Community span a wide range, from US$33.40 up to about US$113.05 per share, showing how far apart individual views can be. Against that backdrop, the emphasis on senior housing driven NOI growth and acquisition led expansion means you should weigh how external growth execution risk might shape Ventas’ future performance before aligning with any single valuation view.

Explore 3 other fair value estimates on Ventas - why the stock might be worth less than half the current price!

Reach Your Own Conclusion

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Ventas research is our analysis highlighting 3 key rewards and 3 important warning signs that could impact your investment decision.
• Our free Ventas research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Ventas' overall financial health at a glance.

Ready For A Different Approach?

Don't miss your shot at the next 10-bagger. Our latest stock picks just dropped:

• The future of work is here. Discover the 31 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
• AI is about to change healthcare. These 40 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• Uncover the next big thing with 24 elite penny stocks that balance risk and reward.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.